Shrikant Mane

机构：University of Iowa, Yale Cancer Center, Yale University, Government Ayurved College, Nanded, Yale New Haven Health System, Genetic Analysis (Norway), Bharati Vidyapeeth (Deemed to be University) · ORCID：0000-0002-3267-5139

发表论文 295 篇 · 总被引 56661 次 · h-index 88

代表论文

• The human and non-human primate developmental GTEx projects (2025 · Nature · 被引 67)
• Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants (2023 · Proceedings of the National Academy of Sciences · 被引 44)
• Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance) (2024 · Journal of Clinical Oncology · 被引 30)
• Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations (2023 · Nature Communications · 被引 28)
• Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genes (2025 · Proceedings of the National Academy of Sciences · 被引 27)
• Dysregulation of mTOR signalling is a converging mechanism in lissencephaly (2025 · Nature · 被引 22)